Feras M. Bader, MD


  • Arabic
  • English

Academic Information

  • Departments: Internal Medicine - Adjunct Associate Professor
  • Divisions: Cardiovascular Medicine

Board Certification

  • American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)

Academic Office Information

  • 801-585-2340
  • School of Medicine
    Division of Cardiology
    30 N 1900 E, Room: 4A100
    Salt Lake City, UT 84132

Academic Bio

Feras Bader, MD, MS, FACC is an Adjunct Professor of Medicine and Cardiology at the University of Utah School of Medicine. In 1992 he received a full scholarship and began his undergraduate and medical training at the University of Jordan School of Medicine in Amman, Jordan; which he completed in 1998. He went on to finish his Internal Medicine Residency at Norwalk Hospital/ Yale University School of Medicine in 2002. He continued at Yale to complete a Heart Failure and Transplant Fellowship in 2003. He came to the University of Utah and completed his Cardiovascular Fellowship in 2006.

Upon completion of his fellowship he joined the faculty as an Assistant Professor at the Division of Cardiology, Section of Heart Failure and Transplant. He currently serves as a Staff Physician in the Heart & Vascular Institute at Cleveland Clinic Abu Dhabi. - https://www.clevelandclinicabudhabi.ae/en/find-a-doctor/pages/feras-bader.aspx#sthash.oidFx0Ff.dpuf . Prior to joining Cleveland Clinic, he served as the Medical Director of the Heart Failure Program at the University of Utah Hospital and the Director of the Advanced Heart Failure and Transplant Fellowship Program at the University of Utah School of Medicine.

Dr Bader is board certified in Internal Medicine, Cardiovascular Diseases, Echocardiography, and Advanced Heart Failure and Transplant Cardiology. His research interests include various aspects in ventricular assist devices, hemodynamics and cardiorenal interaction in heart failure as well as non-invasive diagnosis of rejection in heart transplantation. He has participated in many single and multi-center trials and has published several articles in peer review journals.

Education History

Type School Degree
Graduate Training University of Utah
Clinical Investigation
Fellowship University of Utah School of Medicine
Cardiovascular Diseases
Fellowship Yale New Haven Hospital
Residency Norwalk Hospital, Yale University
Internal Medicine
Internship Norwalk Hospital, Yale University
Internal Medicine
Internship Jordan University Hospital
Rotating Internship
Professional Medical University of Jordan

Global Impact

Education History

Type School Degree Country
Internship Jordan University Hospital
Rotating Internship
Intern Jordan
Professional Medical University of Jordan
M.B.B.S. Jordan

Selected Publications

Journal Article

  1. Nixon JL, Kfoury AG, Brunisholz K, Horne BD, Myrick C, Miller DV, Budge D, Bader F, Everitt M, Saidi A, Stehlik J, Schmidt TC, Alharethi R (2012). Impact of high-dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantation. Clin Transplant, 26(2), 322-7.
  2. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant, 31(1), 46-51.
  3. Karabsheh S, Verma DR, Jain M, Stoddard G, Brunisholz K, Stehlik J, Kfoury A, Gilbert E, Bader F (2011). Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients. Am J Cardiol, 108(12), 1836-9.
  4. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61.
  5. Bader FM, Islam N, Mehta NA, Worthen N, Ishihara S, Stehlik J, Gilbert EM, Litwin SE (2011). Noninvasive diagnosis of cardiac allograft rejection using echocardiography indices of systolic and diastolic function. Transplant Proc, 43(10), 3877-81.
  6. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7.
  7. Saidi A, Akoum N, Bader F (2011). Management of unstable arrhythmias in cardiogenic shock. Curr Treat Options Cardiovasc Med, 13(4), 354-60.
  8. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG (2011). Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart Lung Transplant, 30(2), 144-50.
  9. Bader FM, Gilbert EM, Mehta NA, Bristow MR (2010). Double-blind placebo-controlled comparison of enoximone and dobutamine infusions in patients with moderate to severe chronic heart failure. Congest Heart Fail, 16(6), 265-70.
  10. Hayman MA, Nativi JN, Stehlik J, McDaniel J, Fjeldstad AS, Ives SJ, Walter Wray D, Bader F, Gilbert EM, Richardson RS (2010). Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients. Am J Physiol Heart Circ Physiol, 299(5), H1653-9.
  11. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN (2010). The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. J Thorac Cardiovasc Surg, 140(1), 169-73.
  12. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik J (2010). Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant, 29(3), 235-9.
  13. Stehlik J, Islam N, Hurst D, Kfoury AG, Movsesian MA, Fuller A, Delgado JC, Hammond ME, Gilbert EM, Renlund DG, Bader F, Fisher PW, Bull DA, Singhal AK, Eckels DD (2009). Utility of virtual crossmatch in sensitized patients awaiting heart transplantation. J Heart Lung Transplant, 28(11), 1129-34.
  14. Kfoury AG, Hammond ME, Snow GL, Drakos SG, Stehlik J, Fisher PW, Reid BB, Everitt MD, Bader FM, Renlund DG (2009). Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant, 28(8), 781-4.
  15. Bader FM, Rogers RK, Kfoury AG, Gilbert EM, Horne BD, Stehlik J, Renlund DG (2009). Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function. Congest Heart Fail, 15(2), 63-7.